Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
52
天
Empagliflozin Improves Post-Infarct Heart Failure Through Fibroblast Growth Factor-21 and Ketone Body Oxidation Pathway
作者
Dao-Fu Dai; Ines Martins; Nastaran Daneshgar; Meng Gao; Benjamin Rodriguez; Mohd Mabood Khan; Antentor Jr. Hinton; Peter A. Crawford; Chad Grueter展开收起
作者单位
1. Cardiovascular and Renal Pathology Division, Department of Pathology, School of Medicine, Johns Hopkins University, 632E Ross Building, 720 Rutland Ave, Baltimore, MD 21205, USA; 2. Abboud Cardiovascular Research Center, Department of Internal Medicine, Division of Cardiovascular Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA; 3. Department of Pathology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA; 4. Department of Molecular Physiology & Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; 5. Department of Medicine, and Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA; 6. Fraternal Order of Eagles Diabetes Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA展开收起
144
天
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
